-1%
167,95 €
Statt 169,99 €**
167,95 €
inkl. MwSt.
**Preis der gedruckten Ausgabe (Gebundenes Buch)
Sofort per Download lieferbar
Versandkostenfrei*
84 °P sammeln
-1%
167,95 €
Statt 169,99 €**
167,95 €
inkl. MwSt.
**Preis der gedruckten Ausgabe (Gebundenes Buch)
Sofort per Download lieferbar
Versandkostenfrei*

Alle Infos zum eBook verschenken
84 °P sammeln
Als Download kaufen
Statt 169,99 €**
-1%
167,95 €
inkl. MwSt.
**Preis der gedruckten Ausgabe (Gebundenes Buch)
Sofort per Download lieferbar
84 °P sammeln
Jetzt verschenken
Statt 169,99 €**
-1%
167,95 €
inkl. MwSt.
**Preis der gedruckten Ausgabe (Gebundenes Buch)
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
84 °P sammeln
  • Format: PDF


Drawing on years of significant advances and developments, the editors of this third edition have thoroughly updated the highly praised first and second editions and added new chapters to reflect the knowledge emerging from research on genomics, proteomics, chemoprevention strategies, pharmacogenomics, new molecular targets, therapeutic monoclonal antibodies, and innovative cytotoxic and cytostatic small molecular-weight molecules.…mehr

  • Geräte: PC
  • ohne Kopierschutz
  • eBook Hilfe
  • Größe: 20.24MB
Produktbeschreibung
Drawing on years of significant advances and developments, the editors of this third edition have thoroughly updated the highly praised first and second editions and added new chapters to reflect the knowledge emerging from research on genomics, proteomics, chemoprevention strategies, pharmacogenomics, new molecular targets, therapeutic monoclonal antibodies, and innovative cytotoxic and cytostatic small molecular-weight molecules.

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

  • Produktdetails
  • Verlag: Springer-Verlag GmbH
  • Erscheinungstermin: 16. März 2008
  • Englisch
  • ISBN-13: 9781597454704
  • Artikelnr.: 37350241
Autorenporträt
Miguel H. Bronchud, Universitat Barcelona, Spain / MaryAnn Foote, M A Foote Associates, Los Angeles, CA, USA / Giuseppe Giaccone, National Cancer Inst. (NCI), Bethesda, MD, USA / Olufunmilayo I. Olopade, University of Chicago, Chicago, IL, USA / Paul Workman, Institute of Cancer Research, Surrey, UK
Inhaltsangabe
Selecting the Right Targets for Cancer Therapy.- Clinical Importance of Prognostic Factors.- Genetic Markers in Sporadic Tumors.- Genetic Markers in Breast Tumors with Hereditary Predisposition.- Circulating Tumor Markers.- Antibody-Based Proteomics Analysis of Tumor Cell Signaling Pathways.- Gene Expression Arrays for Pathway Analysis in Cancer Research.- Signaling Pathways in Cancer.- Estrogen Receptor Pathways and Breast Cancer.- Cyclin-Dependent Kinases and Their Regulators as Potential Targets for Anticancer Therapeutics.- Angiogenesis Switch Pathways.- Apoptosis Pathways and New Anticancer Agents.- Genomic Instability, DNA Repair Pathways and Cancer.- Epigenomics and Cancer.- Harnessing the Power of Immunity to Battle Cancer: Much Ado about Nothing or All's Well That Ends Well?.- Aurora Kinases: A New Target for Anticancer Drug Development.- Emerging Molecular Therapies: Drugs Interfering With Signal Transduction Pathways.- Suicide Gene Therapy.- Genotypes That Predict Toxicity and Genotypes That Predict Efficacy of Anticancer Drugs.- A Personal Account of the Chemoprevention of Breast Cancer: Possible or Not Possible?.
Rezensionen
From the reviews of the third edition:

"This is an update of a book of individual reviews of molecular oncology topics written by specialists in the field. ... The intention is to present a broad overview of the concepts in molecular medicine and tumor biology that form the basis of many ongoing drug discovery projects ... . The book is written for a broad audience, including students, house officers and clinical fellows, beginning researchers in cancer biology, and even practitioners of oncology." (Alexander C Minella, Doody's Review Service, 2008)

"The book provides a comprehensive and in-depth view of molecular basis of cancer. ... it is a valuable resource of knowledge for both clinical and experimental oncologists. Those who are interested in the basic understanding of great progress which has been achieved in molecular oncology in last year will enjoy this book as well." (C. Altaner, Neoplasma, September, 2008)